Document is current
Any future updates will be listed below
-
Authors
- License Information
-
More Information
Article History
Received: 19 April 2020
Accepted: 22 June 2020
First Online: 8 September 2020
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: D. Brenner and J. H. Weishaupt own stocks of Ionis Pharmaceuticals. A. C. Ludolph has received financial research support from AB Science, Biogen Idec, Cytokinetics, GSK, Orion Pharam, Novartis, TauRx Therapeutics Ltd. and TEVA Pharmaceuticals. A. C. Ludolph has worked as a consultant for Mitsubishi, Orion Pharma, Novartis and Teva and as a member of the advisory board for Biogen, Treeway and Hoffmann-La Roche.
